Price Alert

Integra LifeSciences Cor... (IART)

NASDAQ: IART · Real-Time Price · USD

13.97

0.35 (2.57%)

At close: Aug 15, 2025, 12:19 PM

Integra LifeSciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	415.61M	382.65M	442.65M	380.83M	418.18M	368.87M	397.04M	382.42M	381.27M	380.85M	398.02M	385.19M	397.81M	376.64M	405.52M	386.86M	389.99M	360.07M
Cost of Revenue	206.27M	188.22M	193.57M	180.6M	185.71M	162.04M	163.06M	164.08M	174.24M	147.97M	147.94M	148.44M	148.4M	142.57M	156.25M	144.47M	151.27M	145.82M
Gross Profit	209.33M	194.43M	249.07M	200.24M	232.47M	206.83M	233.98M	218.34M	207.03M	232.87M	250.09M	236.75M	249.41M	234.07M	249.27M	242.39M	238.72M	214.25M
Operating Income	-512.67M	-15.5M	35.63M	-8.15M	35.25M	3.96M	55.88M	26.59M	12.5M	36.38M	67.84M	65.05M	59.87M	46.16M	58.22M	56.44M	51.85M	30.71M
Interest Income	4.71M	4.42M	4.89M	5.05M	5.06M	5.04M	4.55M	4.61M	3.94M	4.11M	5.31M	3.26M	1.97M	1.38M	1.44M	1.79M	1.76M	1.75M
Pretax Income	-530.95M	-30.04M	22.54M	-20.36M	-15.19M	-5.23M	28.86M	18.61M	3.82M	29.78M	64.21M	58.8M	51.58M	39.31M	51.79M	50.79M	44.82M	67.28M
Net Income	-484.07M	-25.29M	19.43M	-10.7M	-12.4M	-3.28M	19.83M	19.5M	4.18M	24.23M	52.95M	49.91M	44.79M	32.9M	45.38M	43.23M	35.07M	45.39M
Selling & General & Admin	179.89M	181.5M	178.52M	164.94M	172.18M	165.8M	147.44M	161.95M	164.91M	166.66M	151.92M	143.82M	160.65M	159.93M	162.25M	156.01M	162.55M	156.63M
Research & Development	27M	24.73M	31.21M	27.43M	25.03M	26.96M	24.31M	26.6M	26.59M	26.72M	26.78M	24.74M	25.59M	24.09M	24.73M	25.83M	20.12M	22.37M
Other Expenses	515.12M	n/a	3.71M	n/a	1.44M	-610K	-6.35M	471K	-155K	3.11M	3.54M	3.14M	3.3M	3.89M	4.42M	4.99M	5.03M	4.87M
Operating Expenses	722.01M	206.22M	213.44M	208.39M	197.22M	202.87M	178.1M	191.75M	194.52M	196.49M	182.25M	171.7M	189.54M	187.91M	191.05M	185.95M	186.87M	183.53M
Interest Expense	21.04M	-18.82M	18.98M	19.37M	18.65M	13.62M	13.75M	13.06M	12.46M	12.1M	12.89M	12.81M	12.24M	11.65M	12.13M	12.19M	13.15M	12.93M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	928.28M	398.15M	407.02M	388.98M	382.92M	364.91M	341.16M	355.83M	368.76M	344.46M	330.18M	320.14M	337.95M	330.47M	347.3M	330.42M	338.14M	329.36M
Income Tax Expense	-46.88M	-4.74M	3.11M	-9.67M	-2.78M	-1.95M	9.02M	-888K	-360K	5.55M	11.26M	8.88M	6.79M	6.41M	6.4M	7.56M	9.76M	21.88M
Shares Outstanding (Basic)	76.46M	76.46M	77.01M	76.45M	77.41M	77.73M	78.33M	79.69M	80.97M	81.87M	83.65M	83.04M	83.17M	83.63M	84.7M	84.75M	84.69M	84.5M
Shares Outstanding (Diluted)	76.46M	76.46M	77.01M	76.45M	77.41M	77.73M	78.33M	79.81M	81.15M	82.32M	83.65M	83.4M	83.62M	84.28M	85.78M	85.45M	85.34M	85.26M
EPS (Basic)	-6.33	-0.33	0.25	-0.14	-0.16	-0.04	0.25	0.24	0.05	0.30	0.63	0.60	0.54	0.39	0.54	0.51	0.41	0.54
EPS (Diluted)	-6.33	-0.33	0.25	-0.14	-0.16	-0.04	0.25	0.24	0.05	0.29	0.63	0.60	0.54	0.39	0.53	0.51	0.41	0.53
EBITDA	-472.22M	-15.5M	79.11M	39.11M	45.27M	71.07M	78.25M	87.62M	88.53M	92.04M	104.12M	104.71M	102.21M	75.46M	89.89M	88.24M	82.91M	105.24M
EBIT	-509.91M	-48.85M	41.52M	3.15M	3.47M	8.39M	47.73M	31.67M	16.29M	41.88M	74.63M	71.61M	63.81M	45.76M	58.46M	57.55M	52.15M	74.5M
Depreciation & Amortization	37.69M	33.35M	37.49M	35.96M	36.78M	30.57M	30.52M	30.56M	31.32M	32.4M	29.49M	31.11M	31.02M	29.71M	31.43M	30.69M	30.76M	30.74M